158 related articles for article (PubMed ID: 9972771)
1. Dose of compound A, not sevoflurane, determines changes in the biochemical markers of renal injury in healthy volunteers.
Goldberg ME; Cantillo J; Gratz I; Deal E; Vekeman D; McDougall R; Afshar M; Zafeiridis A; Larijani G
Anesth Analg; 1999 Feb; 88(2):437-45. PubMed ID: 9972771
[TBL] [Abstract][Full Text] [Related]
2. Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers.
Eger EI; Gong D; Koblin DD; Bowland T; Ionescu P; Laster MJ; Weiskopf RB
Anesth Analg; 1997 Nov; 85(5):1154-63. PubMed ID: 9356118
[TBL] [Abstract][Full Text] [Related]
3. Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity.
Kharasch ED; Frink EJ; Zager R; Bowdle TA; Artru A; Nogami WM
Anesthesiology; 1997 Jun; 86(6):1238-53. PubMed ID: 9197292
[TBL] [Abstract][Full Text] [Related]
4. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers.
Eger EI; Koblin DD; Bowland T; Ionescu P; Laster MJ; Fang Z; Gong D; Sonner J; Weiskopf RB
Anesth Analg; 1997 Jan; 84(1):160-8. PubMed ID: 8989018
[TBL] [Abstract][Full Text] [Related]
5. Absence of renal and hepatic toxicity after four hours of 1.25 minimum alveolar anesthetic concentration sevoflurane anesthesia in volunteers.
Ebert TJ; Messana LD; Uhrich TD; Staacke TS
Anesth Analg; 1998 Mar; 86(3):662-7. PubMed ID: 9495434
[TBL] [Abstract][Full Text] [Related]
6. Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers.
Ebert TJ; Frink EJ; Kharasch ED
Anesthesiology; 1998 Mar; 88(3):601-10. PubMed ID: 9523801
[TBL] [Abstract][Full Text] [Related]
7. The effects of prolonged low-flow sevoflurane anesthesia on renal and hepatic function.
Obata R; Bito H; Ohmura M; Moriwaki G; Ikeuchi Y; Katoh T; Sato S
Anesth Analg; 2000 Nov; 91(5):1262-8. PubMed ID: 11049919
[TBL] [Abstract][Full Text] [Related]
8. Effects of probenecid on renal function in surgical patients anesthetized with low-flow sevoflurane.
Higuchi H; Wada H; Usui Y; Goto K; Kanno M; Satoh T
Anesthesiology; 2001 Jan; 94(1):21-31. PubMed ID: 11135718
[TBL] [Abstract][Full Text] [Related]
9. Renal toxicity with sevoflurane: a storm in a teacup?
Gentz BA; Malan TP
Drugs; 2001; 61(15):2155-62. PubMed ID: 11772127
[TBL] [Abstract][Full Text] [Related]
10. Long-duration low-flow sevoflurane and isoflurane effects on postoperative renal and hepatic function.
Kharasch ED; Frink EJ; Artru A; Michalowski P; Rooke GA; Nogami W
Anesth Analg; 2001 Dec; 93(6):1511-20, table of contents. PubMed ID: 11726433
[TBL] [Abstract][Full Text] [Related]
11. Role of renal cysteine conjugate beta-lyase in the mechanism of compound A nephrotoxicity in rats.
Kharasch ED; Thorning D; Garton K; Hankins DC; Kilty CG
Anesthesiology; 1997 Jan; 86(1):160-71. PubMed ID: 9009951
[TBL] [Abstract][Full Text] [Related]
12. Comparison of plasma alpha glutathione S-transferase concentrations during and after low-flow sevoflurane or isoflurane anaesthesia.
Higuchi H; Adachi Y; Wada H; Kanno M; Satoh T
Acta Anaesthesiol Scand; 2001 Nov; 45(10):1226-9. PubMed ID: 11736674
[TBL] [Abstract][Full Text] [Related]
13. Effects of low-flow sevoflurane anesthesia on renal function: comparison with high-flow sevoflurane anesthesia and low-flow isoflurane anesthesia.
Bito H; Ikeuchi Y; Ikeda K
Anesthesiology; 1997 Jun; 86(6):1231-7. PubMed ID: 9197291
[TBL] [Abstract][Full Text] [Related]
14. Compound A uptake and metabolism to mercapturic acids and 3,3,3-trifluoro-2-fluoromethoxypropanoic acid during low-flow sevoflurane anesthesia: biomarkers for exposure, risk assessment, and interspecies comparison.
Kharasch ED; Jubert C
Anesthesiology; 1999 Nov; 91(5):1267-78. PubMed ID: 10551576
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of low-flow sevoflurane anaesthesia for paediatric patients.
Igarashi M; Watanabe H; Iwasaki H; Namiki A
Acta Anaesthesiol Scand; 1999 Jan; 43(1):19-23. PubMed ID: 9926182
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the effects of prolonged (>10 hour) low-flow sevoflurane, high-flow sevoflurane, and low-flow isoflurane anaesthesia on hepatorenal function in orthopaedic patients.
Fukuda H; Kawamoto M; Yuge O; Fujii K
Anaesth Intensive Care; 2004 Apr; 32(2):210-8. PubMed ID: 15957718
[TBL] [Abstract][Full Text] [Related]
17. Peripheral neuropathy in healthy men volunteers anesthetized with 1.25 MAC sevoflurane for 8 hours.
Goldberg ME; Larijani GE; Eger EI
Pharmacotherapy; 1999 Oct; 19(10):1173-6. PubMed ID: 10512067
[TBL] [Abstract][Full Text] [Related]
18. Renal and hepatic function in surgical patients after low-flow sevoflurane or isoflurane anesthesia.
Bito H; Ikeda K
Anesth Analg; 1996 Jan; 82(1):173-6. PubMed ID: 8712397
[TBL] [Abstract][Full Text] [Related]
19. Compound A does not accumulate during closed circuit sevoflurane anaesthesia with the Physioflex.
Funk W; Gruber M; Jakob W; Hobbhahn J
Br J Anaesth; 1999 Oct; 83(4):571-5. PubMed ID: 10673871
[TBL] [Abstract][Full Text] [Related]
20. Compound A concentration is decreased by cooling anaesthetic circuit during low-flow sevoflurane anaesthesia.
Osawa M; Shinomura T
Can J Anaesth; 1998 Dec; 45(12):1215-8. PubMed ID: 10051944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
